Khaldoun Tarakji is a Cardiology physician affiliated with Medtronic. OpenAlex indexes 228 publications with 7,642 citations (h-index 43); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9500 Euclid Ave # F15
Cleveland, OH 441950001
Telephone
216-444-2200Registry record last updated 2 May 2008.
Clinical trials
- Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
Sponsor: Medtronic Cardiac Ablation Solutions
- PULSED AF Post-Approval Study
Sponsor: Medtronic Cardiac Ablation Solutions
- PulseSelect™ PFA Global Registry
Sponsor: Medtronic Cardiac Ablation Solutions
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year20223 payments
- Janssen Scientific Affairs, LLCProgram year20221 payment
- Medtronic, Inc.Program year202113 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
66.2%Factor Xa inhibitor66.2%Eliquis81%Xarelto19%Part D<11 patientsCardiovascular
33.8%Beta blocker28.4%Metoprolol Succinate59%Metoprolol Tartrate41%Part D<11 patientsAntiarrhythmic5.4%Flecainide Acetate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Effect of contact force on pulsed field ablation lesions in porcine cardiac tissue
Journal of Cardiovascular Electrophysiology
2023 - Smart wearable devices in cardiovascular care: where we are and how to move forward
Nature Reviews Cardiology
2021 - Incidence, Predictors, and Implications of Permanent Pacemaker Requirement After Transcatheter Aortic Valve Replacement
JACC: Cardiovascular Interventions
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”